Literature DB >> 31526804

TNF induces production of type 2 cytokines in human group 2 innate lymphoid cells.

Noriko Ogasawara1, Julie A Poposki2, Aiko I Klingler2, Bruce K Tan3, Kathryn E Hulse2, Whitney W Stevens2, Anju T Peters2, Leslie C Grammer2, Kevin C Welch3, Stephanie S Smith3, David B Conley3, Ken-Ichi Takano4, Tetsuo Himi4, Robert C Kern5, Robert P Schleimer5, Atsushi Kato6.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2019        PMID： 31526804      PMCID： PMC6949387          DOI： 10.1016/j.jaci.2019.09.001

Source DB:  PubMed          Journal:  J Allergy Clin Immunol        ISSN： 0091-6749            Impact factor:   10.793


× No keyword cloud information.
  8 in total

1.  Efficacy and safety of etanercept in moderate-to-severe asthma: a randomised, controlled trial.

Authors:  S T Holgate; M Noonan; P Chanez; W Busse; L Dupont; I Pavord; A Hakulinen; L Paolozzi; J Wajdula; C Zang; H Nelson; D Raible
Journal:  Eur Respir J       Date:  2010-11-25       Impact factor: 16.671

Review 2.  The group 2 innate lymphoid cell (ILC2) regulatory network and its underlying mechanisms.

Authors:  Hiroki Kabata; Kazuyo Moro; Shigeo Koyasu
Journal:  Immunol Rev       Date:  2018-11       Impact factor: 12.988

3.  GITR cosignal in ILC2s controls allergic lung inflammation.

Authors:  Hiroyuki Nagashima; Yuko Okuyama; Tsuyoshi Fujita; Takeo Takeda; Yasutaka Motomura; Kazuyo Moro; Takanori Hidaka; Koki Omori; Tsuyoshi Sakurai; Tomoaki Machiyama; Lishomwa C Ndhlovu; Carlo Riccardi; Takanori So; Naoto Ishii
Journal:  J Allergy Clin Immunol       Date:  2018-02-08       Impact factor: 10.793

Review 4.  Precision medicine and phenotypes, endotypes, genotypes, regiotypes, and theratypes of allergic diseases.

Authors:  Ioana Agache; Cezmi A Akdis
Journal:  J Clin Invest       Date:  2019-03-11       Impact factor: 14.808

Review 5.  Group 2 Innate Lymphoid Cells in Airway Diseases.

Authors:  Atsushi Kato
Journal:  Chest       Date:  2019-05-10       Impact factor: 9.410

6.  Group 2 innate lymphoid cells are elevated and activated in chronic rhinosinusitis with nasal polyps.

Authors:  Julie A Poposki; Aiko I Klingler; Bruce K Tan; Pejman Soroosh; Homayon Banie; Gavin Lewis; Kathryn E Hulse; Whitney W Stevens; Anju T Peters; Leslie C Grammer; Robert P Schleimer; Kevin C Welch; Stephanie S Smith; David B Conley; Joseph R Raviv; James G Karras; Omid Akbari; Robert C Kern; Atsushi Kato
Journal:  Immun Inflamm Dis       Date:  2017-04-19

Review 7.  Helminth Infections: Recognition and Modulation of the Immune Response by Innate Immune Cells.

Authors:  Claudia Cristina Motran; Leonardo Silvane; Laura Silvina Chiapello; Martin Gustavo Theumer; Laura Fernanda Ambrosio; Ximena Volpini; Daiana Pamela Celias; Laura Cervi
Journal:  Front Immunol       Date:  2018-04-04       Impact factor: 7.561

8.  TNF superfamily member TL1A elicits type 2 innate lymphoid cells at mucosal barriers.

Authors:  X Yu; R Pappu; V Ramirez-Carrozzi; N Ota; P Caplazi; J Zhang; D Yan; M Xu; W P Lee; J L Grogan
Journal:  Mucosal Immunol       Date:  2013-11-13       Impact factor: 7.313
  8 in total
  3 in total

1.  Innate Immune Responses and Pulmonary Diseases.

Authors:  Tao Liu; Siqi Liu; Xiaobo Zhou
Journal:  Adv Exp Med Biol       Date:  2021       Impact factor: 2.622

Review 2.  The role of meningeal populations of type II innate lymphoid cells in modulating neuroinflammation in neurodegenerative diseases.

Authors:  Sherry Sin-Hang Yeung; Yuen-Shan Ho; Raymond Chuen-Chung Chang
Journal:  Exp Mol Med       Date:  2021-09-06       Impact factor: 12.153

Review 3.  Group 2 innate lymphoid cells in nasal polyposis.

Authors:  Whitney W Stevens; Atsushi Kato
Journal:  Ann Allergy Asthma Immunol       Date:  2020-08-08       Impact factor: 6.347
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.